Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

TELO — Telomir Pharmaceuticals, Inc. Dilution Risk Tracker

Track TELO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TELO — Get alerts when the score changes →

As of August 28, 2026, Telomir Pharmaceuticals, Inc. (TELO) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Telomir Pharmaceuticals, Inc. has a market capitalization of $89.41M, 68.77M shares outstanding, 30 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
95
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 43%
💰 Capital Raise model 55%
• Critical: only 1.7 months cash remaining
🔄 Reverse Split model est. 45%
• 50-day avg $1.32 approaching $1 threshold
• Only 2 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track TELO — Get forecast alerts →

Market Data

Market Cap$89.41M
Shares Outstanding68.77M
Float38.06M
Cash$754.3K
Debt$202.9K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 42.6% shares (2026Q1 vs prior)
30 institutional holders · 3.34M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.99M shares
#2 BlackRock, Inc. 289.2K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 249.1K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest963.3K
Days to Cover6.8
% of Float2.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31
xbrl XBRL CONVERTIBLE 2023-12-31
4 INSIDER TRANSACTION 2026-04-24
8-K 8K EVENT 2026-04-24
8-K 8K EVENT 2026-03-27
Full SEC filing analysis available with free account

Recent News

No recent news

Factual TELO Dilution Snapshot

Telomir Pharmaceuticals, Inc. (TELO) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track TELO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TELO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TELO
TELO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.